{"disease":{"id":"participants-who-had-received-second-line-or-higher-advanced-melanoma-and-advanced-renal-cancer","name":"participants who had received second line or higher advanced melanoma and advanced renal cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06670300","title":"Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"YongZhang","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}